Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Sulfacetamide

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 90Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Enforcement Report - Week of July 5, 2017
    Enforcement Report - Week of July 5, 2017

    05 Jul 2017

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-july-5-2017-1499230453.pdf

    FDA
    05 Jul 2017
    Share Share
    Enforcement Report - Week of March 22, 2017
    Enforcement Report - Week of March 22, 2017

    22 Mar 2017

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-22-2017-1490161550.pdf

    FDA
    22 Mar 2017
    Share Share
    US FDA Enforcement Report- 8/June/2016
    US FDA Enforcement Report- 8/June/2016

    08 Jun 2016

    // FDA

    https://www.pharmacompass.com/pdf/news/us-fda-enforcement-report-8june2016-1465388450.pdf

    FDA
    08 Jun 2016
    Share Share